Evaluation of risk of symptomatic cytomegalovirus reactivation in myeloma patients treated with tandem autologous stem cell transplantation and novel agents: a single-institution study. [electronic resource]
Producer: 20150827Description: 1032-8 p. digitalISSN:- 1399-3062
- Adult
- Aged
- Antineoplastic Agents -- therapeutic use
- Antineoplastic Combined Chemotherapy Protocols -- administration & dosage
- Boronic Acids -- administration & dosage
- Bortezomib
- Cytomegalovirus Infections -- pathology
- Dexamethasone -- administration & dosage
- Doxorubicin -- administration & dosage
- Female
- Humans
- Immunologic Factors -- administration & dosage
- Male
- Middle Aged
- Multiple Myeloma -- therapy
- Pyrazines -- administration & dosage
- Retrospective Studies
- Risk Factors
- Stem Cell Transplantation
- Vincristine -- administration & dosage
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.